Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice

DMM Disease Models and Mechanisms

Volumn 2, Issue 5-6, 2009, Pages 283-294

  Catela, Catarina ^a   Bilbao Cortes, Daniel ^a   Slonimsky, Esfir ^a   Kratsios, Paschalis ^a   Rosenthal, Nadia ^a   Te Welscher, Pascal ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL HEART MALFORMATION; FEMALE; GENE EXPRESSION; GENOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETON MALFORMATION; WOLF HIRSCHHORN SYNDROME; ALLELE; ANIMAL; ANIMAL EMBRYO; BONE; CONGENITAL MALFORMATION; FETUS; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC RECOMBINATION; GENETICS; HEART VALVE; HEART VENTRICLE SEPTUM; HOMOZYGOTE; METABOLISM; MOUSE MUTANT; NEWBORN; PATHOLOGY; PLACENTA; PRENATAL DEVELOPMENT; SEQUENCE HOMOLOGY; SEXUAL DEVELOPMENT;

ANIMALIA; MUS;

FGFRL1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR 5;

ALLELES; ANEMIA; ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; EMBRYO, MAMMALIAN; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; HEART DEFECTS, CONGENITAL; HEART SEPTUM; HEART VALVES; HOMOZYGOTE; MICE; MICE, KNOCKOUT; PLACENTA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 5; RECOMBINATION, GENETIC; SEQUENCE HOMOLOGY, NUCLEIC ACID; SEX CHARACTERISTICS; WOLF-HIRSCHHORN SYNDROME;

EID: 67650323999     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.002287     Document Type: Article

References (47)

1. Angrand, P. O., Daigle, N., van der Hoeven, F., Scholer, H. R. and Stewart, A. F. (1999). Simplified generation of targeting constructs using ET recombination. Nucleic Acids Res. 27, e16.
2. Baertschi, S., Zhuang, L. and Trueb, B. (2007). Mice with a targeted disruption of the Fgfrl1 gene die at birth due to alterations in the diaphragm. FEBS J. 274, 6241-6253. (Pubitemid 350135342)
3. Battaglia, A., Carey, J. C. and Wright, T. J. (2001). Wolf-Hirschhorn (4p-) syndrome. Adv. Pediatr. 48, 75-113.
4. Becker, D. J., Myers, J. T., Ruff, M. M., Smith, P. L., Gillespie, B. W., Ginsburg, D. W. and Lowe, J. B. (2003). Strain-specific modification of lethality in fucose-deficient mice. Mamm. Genome 14, 130-139.
5. Bergemann, A. D., Cole, F. and Hirschhorn, K. (2005). The etiology of Wolf- Hirschhorn syndrome. Trends Genet. 21, 188-195.
6. Beyeler, M. and Trueb, B. (2006). Fgfrl1, a fibroblast growth factor receptor-like gene, is found in the cephalochordate Branchiostoma floridae but not in the urochordate Ciona intestinalis. Comp. Biochem. Physiol. B 145, 43-49. (Pubitemid 44279482)
7. Bottcher, R. T. and Niehrs, C. (2005). Fibroblast growth factor signaling during early vertebrate development. Endocr. Rev. 26, 63-77. (Pubitemid 40209387)
8. Cebria, F., Kobayashi, C., Umesono, Y., Nakazawa, M., Mineta, K., Ikeo, K., Gojobori, T., Itoh, M., Taira, M., Sanchez Alvarado, A. et al. (2002). FGFR-related gene nou-darake restricts brain tissues to the head region of planarians. Nature 419, 620-624.
9. Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G. and Ornitz, D. M. (1996). Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390-397.
10. Connerney, J., Andreeva, V., Leshem, Y., Mercado, M. A., Dowell, K., Yang, X., Lindner, V., Friesel, R. E. and Spicer, D. B. (2008). Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev. Biol. 318, 323-334.
11. de Lange, F. J., Moorman, A. F., Anderson, R. H., Manner, J., Soufan, A. T., de Gierde Vries, C., Schneider, M. D., Webb, S., van den Hoff, M. J. and Christoffels, V. M. (2004). Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 95, 645-654. (Pubitemid 39274380)
12. Engbers, H., van der Smagt, J. J., van't Slot, R., Vermeesch, J. R., Hochstenbach, R. and Poot, M. (2009). Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions. Eur. J. Hum. Genet. 17, 129-132.
13. Frank, D. U., Fotheringham, L. K., Brewer, J. A., Muglia, L. J., Tristani-Firouzi, M., Capecchi, M. R. and Moon, A. M. (2002). An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129, 4591-4603. (Pubitemid 35203740)
14. Hall, C., Flores, M. V., Murison, G., Crosier, K. and Crosier, P. (2006). An essential role for zebrafish Fgfrl1 during gill cartilage development. Mech. Dev. 123, 925-940. (Pubitemid 44820822)
15. Hayashi, S., Itoh, M., Taira, S., Agata, K. and Taira, M. (2004). Expression patterns of Xenopus FGF receptor-like 1/nou-darake in early Xenopus development resemble those of planarian nou-darake and Xenopus FGF8. Dev. Dyn. 230, 700-707. (Pubitemid 38993869)
16. Kim, I., Moon, S., Yu, K., Kim, U. and Koh, G. Y. (2001). A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1). Biochim. Biophys. Acta 1518, 152-156. (Pubitemid 32232288)
17. Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nature 423, 332-336.
18. Lazarus, J. E., Hegde, A., Andrade, A. C., Nilsson, O. and Baron, J. (2007). Fibroblast growth factor expression in the postnatal growth plate. Bone 40, 577-586. (Pubitemid 46187233)
19. LeCouter, J. E., Kablar, B., Whyte, P. F., Ying, C. and Rudnicki, M. A. (1998). Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125, 4669-4679. (Pubitemid 29027197)
20. Maas, N. M., Van Buggenhout, G., Hannes, F., Thienpont, B., Sanlaville, D., Kok, K., Midro, A., Andrieux, J., Anderlid, B. M., Schoumans, J. et al. (2008). Genotypephenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH). J. Med. Genet. 45, 71-80. (Pubitemid 351252869)
21. Magill, H. L., Shackelford, G. D., McAlister, W. H. and Graviss, E. R. (1980). 4p- (Wolf- Hirschhorn) syndrome. AJR Am. J. Roentgenol. 135, 283-288.
22. Murakami, S., Balmes, G., McKinney, S., Zhang, Z., Givol, D. and de Crombrugghe, B. (2004). Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 18, 290-305. (Pubitemid 38199254)
23. Murphy, W. J., Eizirik, E., Johnson, W. E., Zhang, Y. P., Ryder, O. A. and O'Brien, S. J. (2001). Molecular phylogenetics and the origins of placental mammals. Nature 409, 614-618. (Pubitemid 32154812)
24. Näf, D., Wilson, L. A., Bergstrom, R. A., Smith, R. S., Goodwin, N. C., Verkerk, A., van Ommen, G. J., Ackerman, S. L., Frankel, W. N. and Schimenti, J. C. (2001). Mouse models for the Wolf-Hirschhorn deletion syndrome. Hum. Mol. Genet. 10, 91-98. (Pubitemid 32098118)
25. Naski, M. C., Colvin, J. S., Coffin, J. D. and Ornitz, D. M. (1998). Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125, 4977-4988.
26. Noden, D. M. and Trainor, P. A. (2005). Relations and interactions between cranial mesoderm and neural crest populations. J. Anat. 207, 575-601.
27. Rieckmann, T., Kotevic, I. and Trueb, B. (2008). The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion. Exp. Cell Res. 314, 1071-1081. (Pubitemid 351273200)
28. Rieckmann, T., Zhuang, L., Flück, C. E. and Trueb, B. (2009). Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient. Biochim. Biophys. Acta 1792, 112-121.
29. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J. M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994). Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252-254. (Pubitemid 24293024)
30. Schwenk, F., Baron, U. and Rajewsky, K. (1995). A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081. (Pubitemid 26012492)
31. Sharathkumar, A., Kirby, M., Freedman, M., Abdelhaleem, M., Chitayat, D., Teshima, I. E. and Dror, Y. (2003). Malignant hematological disorders in children with Wolf-Hirschhorn syndrome. Am. J. Med. Genet. A 119A, 194-199. (Pubitemid 37063893)
32. Shiang, R., Thompson, L. M., Zhu, Y. Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T. and Wasmuth, J. J. (1994). Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335-342. (Pubitemid 24241100)
33. Sleeman, M., Fraser, J., McDonald, M., Yuan, S., White, D., Grandison, P., Kumble, K., Watson, J. D. and Murison, J. G. (2001). Identification of a new fibroblast growth factor receptor, FGFR5. Gene 271, 171-182. (Pubitemid 32545394)
34. South, S. T., Hannes, F., Fish, G. S., Vermeesch, J. R. and Zollino, M. (2008). Pathogenic significance of deletions distal to the currently discribed Wolf-Hirschhorn syndrome critical regions on 4p16.3. Am. J. Med. Genet. C Semin. Med. Genet. 148C, 275-280.
35. Stoller, J. Z. and Epstein, J. A. (2005). Cardiac neural crest. Semin. Cell Dev. Biol. 16, 704-715.
36. Sugi, Y., Ito, N., Szebenyi, G., Myers, K., Fallon, J. F., Mikawa, T. and Markwald, R. R. (2003). Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev. Biol. 258, 252-263. (Pubitemid 36683129)
37. Teng, A., Nair, M., Wells, J., Segre, J. A. and Dai, X. (2007). Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermis. Biochim. Biophys. Acta 1772, 89-95. (Pubitemid 44960722)
38. te Welscher, P., Zuniga, A., Kuijper, S., Drenth, T., Goedemans, H. J., Meijlink, F. and Zeller, R. (2002). Progression of vertebrate limb development through SHHmediated counteraction of GLI3. Science 298, 827-830.
39. Thisse, B. and Thisse, C. (2005). Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 287, 390-402. (Pubitemid 41636772)
40. Trueb, B. and Taeschler, S. (2006). Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development. Int. J. Mol. Med. 17, 617-620.
41. Trueb, B., Zhuang, L., Taeschler, S. and Wiedemann, M. (2003). Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor preferentially expressed in skeletal tissues. J. Biol. Chem. 278, 33857-33865. (Pubitemid 37553220)
42. Trueb, B., Neuhauss, S. C., Baertschi, S., Rieckmann, T., Schild, C. and Taeschler, S. (2005). Fish possess multiple copies of fgfrl1, the gene for a novel FGF receptor. Biochim. Biophys. Acta 1727, 65-74. (Pubitemid 40093504)
43. van Dooren, M. F., Brooks, A. S., Hoogeboom, A. J., van den Hoonaard, T. L., de Klein, J. E., Wouters, C. H. and Tibboel, D. (2004). Early diagnosis of Wolf- Hirschhorn syndrome triggered by a life-threatening event: congenital diaphragmatic hernia. Am. J. Med. Genet. A 127A, 194-196.
44. Walshe, J. and Mason, I. (2003). Fgf signalling is required for formation of cartilage in the head. Dev. Biol. 264, 522-536. (Pubitemid 37492973)
45. Wiedemann, M. and Trueb, B. (2000). Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. Genomics 69, 275-279. (Pubitemid 30815828)
46. Wiedemann, M. and Trueb, B. (2001). The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. Biochim. Biophys. Acta 1520, 247-250. (Pubitemid 32868796)
47. Zhang, J., Socolovsky, M., Gross, A. W. and Lodish, H. F. (2003). Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102, 3938-3946. (Pubitemid 37486974)